Post-approval studies (Phase 4)Study completedNCT05057819
What this trial is testing
Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass
Who this might be right for
Dumping SyndromeHypoglycemia, Reactive
Insel Gruppe AG, University Hospital Bern 22